ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.

about

Association between serum free fatty acid levels and possible related factors in patients with type 2 diabetes mellitus and acute myocardial infarction.

P2860

Q34537384-D714BD2C-27C6-435C-80F8-A1105A4E9A3C

P2860

ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.

Item

http://www.wikidata.org/entity/Q38167825

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.

@en

type

Item

label

ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.

@en

prefLabel

ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.

@en

P1476

ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.

@en

P2093

Allan Sniderman

http://www.w3.org/2001/XMLSchema#string

Jacqueline de Graaf

http://www.w3.org/2001/XMLSchema#string

Tjerk de Nijs

http://www.w3.org/2001/XMLSchema#string

P2860

LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1.

Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses.

Clinical implications of discordance between low-density lipoprotein cholesterol and particle number.

Major lipids, apolipoproteins, and risk of vascular disease.

Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans.

Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices.

Recent progress in understanding apolipoprotein B.

P304

163-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10408363.2013.847897

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24295059

http://www.w3.org/2001/XMLSchema#string

ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.

about

P2860

P2860

ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698